Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1379 of 6351
-
New sensor could help preterm babies breathe easier
Diagnosis Recruiting nowExtremely preterm infants, born before 29 weeks of pregnancy, often face breathing difficulties, also known as respiratory events, due to their undeveloped lungs and respiratory systems. These respiratory events include pauses in breathing, shallows breaths, and irregular breathi…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat leukemia
Disease control OngoingThe goal of Phase 1 is to find the recommended dose of ziftomenib and olutasidenib in patients with relapsed/refractory AML that has a mutation in the NPM1 and IDH1 genes. The goal of Phase 1b is to learn if the recommended dose of ziftomenib and olutasidenib found in Phase 1 ca…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New drug takes aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThe purpose of this study is to find the best dose of the drug and measure the safety and efficacy of LY4152199 in participants with previously treated B-cell malignancies. Participants will have the option to continue taking LY4152199 until the study ends.
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New pill could help shed pounds: obesity drug trial begins
Disease control Recruiting nowThe primary objective is to assess the safety and tolerability of oral dose ERX1000 in obese subjects.
Phase 2 • Sponsor: ERX Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a cancer drug and smart brace boost mobility in kids with cerebral palsy?
Disease control Recruiting nowThis is an intervention study to investigate the impact of a smart ankle-foot orthosis (AFO) on mobility outcomes in children with Cerebral Palsy. Participants will complete a three phase protocol including 6-weeks of at home training with the smart AFO. Participants will also ha…
Phase 2 • Sponsor: Shirley Ryan AbilityLab • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug duo aims to stop kidney rejection in its tracks
Disease control Recruiting nowThe purpose of this study is to evaluate the safety of carfilzomib and belatacept, administered with steroids and maintenance immunosuppression, in kidney transplant recipients with donor-specific antibody (DSA)-associated graft injury. Participants will be followed for 52 weeks …
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a magnetic helmet help kids with delayed speech?
Symptom relief Recruiting nowThis study explores a safe and effective new approach to improve language function in children with Global Developmental Delay (GDD). Conducted at Xiangxi Autonomous Prefecture People's Hospital, the study will recruit approximately 50 children aged 2 to 5 years. Participants wil…
Sponsor: Xiangya Hospital of Central South University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could an ancient herb keep breast cancer at bay?
Disease control CompletedAstragalus polysaccharides (APS), acting as an immunomodulator, is known to modulate the tumor microenvironment and inhibit tumor growth and progression, thereby suggesting potential as an adjuvant cancer therapy to improve treatment outcomes. PG2 (APS Injection) has completed a…
Sponsor: Kun-Ming Rau • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Experimental drug targets Low-Oxygen tumors in prostate cancer
Disease control Not yet recruitingThis is a single-institution, single-arm, open-label Phase 2 trial evaluating evofosfamide in subjects with M1 CRPC who fail first-line ARSIs. In those progressing after second-line Docetaxel or deemed ineligible to it, the use of alternate ARSI remains the most common line of th…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo targets Hard-to-Treat lung cancer
Disease control Recruiting nowThe researchers are doing this study to find out whether the combination of tepotinib and ivonescimab is a safe and effective treatment for people with non-small cell lung cancer (NSCLC) that is positive for METex14 skipping. The researchers will test up to two different doses of…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Carpal tunnel surgery could spot hidden heart disease risk
Diagnosis Recruiting nowTransthyretin amyloidosis (ATTR) is an underdiagnosed condition that can present early as carpal tunnel syndrome, sometimes preceding cardiac involvement by several years. The recent emergence of new treatments underscores the importance of early diagnosis. Synovial biopsy perfor…
Sponsor: Clinique Saint Jean, France • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New triple therapy aims to wipe out rectal cancer before surgery
Disease control OngoingThis study aims to evaluate the efficacy and safety of neoadjuvant short-course radiotherapy combined with Retlirafusp alfa and CAPOX chemotherapy in the treatment of locally advanced rectal cancer. This is a prospective, single-arm, phase II clinical trial planned to enroll 44 p…
Phase 2 • Sponsor: Harbin Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
A simple urine test and a smart alert may help predict kidney failure in sick kids
Disease control Recruiting nowThe goal of this study is to learn whether adding a clinical decision support tool to the electronic medical record helps clinicians use the furosemide stress test in critically ill children at high risk for severe acute kidney injury (AKI). The main question it aims to answer is…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
A helping hand in the maternity ward: does it boost breastfeeding?
Disease control Recruiting nowThe first months of life are considered a critical period that has a lasting impact on a child's future health. Breastfeeding is one of the fundamental factors contributing to healthy growth in children. It is reducing infant mortality, and supporting neurocognitive development.…
Sponsor: Centre Hospitalier de Cayenne • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a single CT scan spot lung cancer and other diseases early?
Diagnosis Recruiting nowLung cancer is one of the most common and serious cancers in Scotland and is often diagnosed at a late stage. Early detection is crucial to improving survival rates. The value of screening for lung cancer with low-dose CT (LDCT) scans has been established, and these scans can als…
Sponsor: NHS Greater Glasgow and Clyde • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New injection aims to revive immune system in HIV patients
Disease control Recruiting nowThe Phase Ib clinical trial is an add-on study based on combination antiretroviral therapy (cART). It adopts a multicenter, randomized, double-blind, placebo-controlled, multiple-dose design to evaluate the safety and efficacy of multiple intramuscular injections of JL18008 added…
Phase 1/2 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a Cholesterol-Lowering drug stop brain arteries from narrowing further?
Disease control Recruiting nowThe goal of this clinical trial is to learn whether pemafibrate can help prevent worsening of intracranial arterial stenosis (ICAS) in patients who have symptomatic ICAS and high triglycerides (TG) levels after ischemic stroke or transient ischemic attack (TIA). The main questio…
Sponsor: Tokyo Women's Medical University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New water treatment could slash diarrhea in nigerian villages
Prevention Not yet recruitingThis study evaluates the implementation and effectiveness of in-line chlorination (ILC) for improving drinking water quality in rural Nigeria. Unsafe drinking water remains a major contributor to diarrheal disease, particularly among children under five. Inline chlorination is a …
Sponsor: University of California, Berkeley • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Experimental immune therapy aims to reduce deaths in severe pneumonia
Disease control Recruiting nowThis clinical trial will evaluate the efficacy and safety of a single intravenous dose of agenT-797 administered in addition to standard of care (SOC), compared with placebo plus SOC, in reducing short-term mortality in adult participants with severe pneumonia and moderate to sev…
Phase 2 • Sponsor: MiNK Therapeutics • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New HPV vaccine batch trial aims to ensure reliable protection
Vaccine Recruiting nowTo support international market access and comply with World Health Organization Prequalification requirements, this lot-to-lot consistency trial is planned for initiation. The goal of this clinical trial is to evaluate lot-to-lot immunogenicity and safety of Recombinant Human Pa…
Phase 4 • Sponsor: Xiamen Innovax Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 14:02 UTC